Isofol Medical AB

Isofol | ISO-CC-007

NCT03750786

JCP058

A Study to Compare the Efficacy of Arfolitixorin Versus Leucovorin in Combination With 5 Fluorouracil, Oxaliplatin, and Bevacizumab in Patients With Advanced Colorectal Cancer (AGENT)

Status:

On Hold

26459-200.png

III

Phase

Line of Therapy.png

1st

Line of Therapy

Disease Stage.png

Advanced / Metastatic

Disease Stage

Target.png

Biomarker(s)

N/A

Investigational

Product

Arfolitixorin

Treatment Arms

o Experimental: Group A
ARFOX and Bevacizumab

o Active Comparator: Group B
mFOLFOX-6 and Bevacizumab